Rectal cancer treatment response study using gene testing
Part of Cancer, Digestive system clinical trials.
This study looks at how well rectal cancer responds to chemotherapy and radiation before surgery. It uses a genetic test on tumor tissue to predict whether the treatment will work for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and male or cannot become pregnant.
- You have rectal cancer confirmed by a biopsy.
- You are planning to receive chemotherapy or radiation before surgery as recommended by your doctor.
- You have tumor tissue from a biopsy that can be used for genetic testing.
- You do not have any other type of cancer.
- You agree to join the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how rectal cancer responds to the usual chemotherapy and radiation given before surgery. It aims to learn if certain molecular features of your tumor can predict how well it responds to treatment.
This study looks at how your genetic makeup and response to radiation might help predict how well you will respond to chemotherapy and radiation therapy given before surgery for locally advanced rectal cancer. It may help doctors better personalize your treatment plan.
This trial studies lab “biomarkers” (measurable cancer features) to predict whether rectal cancer will resist chemo-radiation before surgery. The goal is to help doctors better choose treatments and avoid ineffective therapy.
This trial is looking at whether a simple blood test (ctDNA monitoring) can help predict how well total neoadjuvant therapy (chemo and radiation before surgery) works for rectal cancer. It may help doctors tailor treatment to your specific needs.
This trial tests whether checking for tumor DNA in your blood after surgery can help decide if you need additional chemotherapy. If the test finds cancer DNA, you may get chemo to lower the risk of the cancer coming back.
This study looks at molecular (tumor biology) features of rectal cancer in people receiving standard short-course radiation. Your tissue and/or samples may be used to better understand the cancer and how it responds to treatment.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.